Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Mexico launches leukaemia therapy/testing plan

This article was originally published in Clinica

Executive Summary

A Mexican initiative to provide universal treatment for chronic myeloid leukaemia will also cover the associated therapy-monitoring testing. So promised the health ministry of the "very expensive laboratory tests required by patients every three or four months". The project, announced last week, is being is being co-ordinated by the national cancer institute (INCAN), with the support of Mexico's AMANC Foundation and Novartis.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts